Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep 6;103(3):319-327.
doi: 10.1016/j.ajhg.2018.08.007.

The Clinical Sequencing Evidence-Generating Research Consortium: Integrating Genomic Sequencing in Diverse and Medically Underserved Populations

Affiliations

The Clinical Sequencing Evidence-Generating Research Consortium: Integrating Genomic Sequencing in Diverse and Medically Underserved Populations

Laura M Amendola et al. Am J Hum Genet. .

Abstract

The Clinical Sequencing Evidence-Generating Research (CSER) consortium, now in its second funding cycle, is investigating the effectiveness of integrating genomic (exome or genome) sequencing into the clinical care of diverse and medically underserved individuals in a variety of healthcare settings and disease states. The consortium comprises a coordinating center, six funded extramural clinical projects, and an ongoing National Human Genome Research Institute (NHGRI) intramural project. Collectively, these projects aim to enroll and sequence over 6,100 participants in four years. At least 60% of participants will be of non-European ancestry or from underserved settings, with the goal of diversifying the populations that are providing an evidence base for genomic medicine. Five of the six clinical projects are enrolling pediatric patients with various phenotypes. One of these five projects is also enrolling couples whose fetus has a structural anomaly, and the sixth project is enrolling adults at risk for hereditary cancer. The ongoing NHGRI intramural project has enrolled primarily healthy adults. Goals of the consortium include assessing the clinical utility of genomic sequencing, exploring medical follow up and cascade testing of relatives, and evaluating patient-provider-laboratory level interactions that influence the use of this technology. The findings from the CSER consortium will offer patients, healthcare systems, and policymakers a clearer understanding of the opportunities and challenges of providing genomic medicine in diverse populations and settings, and contribute evidence toward developing best practices for the delivery of clinically useful and cost-effective genomic sequencing in diverse healthcare settings.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structure of the CSER Consortium The components of the CSER consortium and their relationships to each other.

References

    1. Green R.C., Goddard K.A.B., Jarvik G.P., Amendola L.M., Appelbaum P.S., Berg J.S., Bernhardt B.A., Biesecker L.G., Biswas S., Blout C.L., CSER Consortium Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine. Am. J. Hum. Genet. 2016;98:1051–1066. - PMC - PubMed
    1. Yavarna T., Al-Dewik N., Al-Mureikhi M., Ali R., Al-Mesaifri F., Mahmoud L., Shahbeck N., Lakhani S., AlMulla M., Nawaz Z. High diagnostic yield of clinical exome sequencing in Middle Eastern patients with Mendelian disorders. Hum. Genet. 2015;134:967–980. - PubMed
    1. Lee K., Berg J.S., Milko L., Crooks K., Lu M., Bizon C., Owen P., Wilhelmsen K.C., Weck K.E., Evans J.P., Garg S. High Diagnostic Yield of Whole Exome Sequencing in Participants With Retinal Dystrophies in a Clinical Ophthalmology Setting. Am. J. Ophthalmol. 2015;160:354–363.e9. - PMC - PubMed
    1. Yang Y., Muzny D.M., Xia F., Niu Z., Person R., Ding Y., Ward P., Braxton A., Wang M., Buhay C. Molecular findings among patients referred for clinical whole-exome sequencing. JAMA. 2014;312:1870–1879. - PMC - PubMed
    1. Amendola L.M., Dorschner M.O., Robertson P.D., Salama J.S., Hart R., Shirts B.H., Murray M.L., Tokita M.J., Gallego C.J., Kim D.S. Actionable exomic incidental findings in 6503 participants: challenges of variant classification. Genome Res. 2015;25:305–315. - PMC - PubMed

Publication types